DILATREND
|
Siegfried
|
carvedilol |
Antianginoso Antihipertensivo |
12.5 mg comp.ran.x 28 | $15.590,40 | (24/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $4.624,31 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $8.844,72 AF $6.745,68 |
|
|
|
|
12.5 mg comp.ran.x 30 | $16.058,11 | (24/07/25) |
PAMI |
|
AF $4.830,63 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $9.097,50 AF $6.960,61 |
|
|
|
|
12.5 mg comp.ran.x 56 | $25.466,42 | (24/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $6.438,44 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $15.142,54 AF $10.323,88 |
|
|
|
|
25 mg comp.ran.x 28 | $19.852,14 | (24/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $5.443,82 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $11.217,77 AF $8.634,37 |
|
|
|
|
25 mg comp.ran.x 30 | $19.851,82 | (24/07/25) |
PAMI |
|
AF $5.638,31 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $11.235,45 AF $8.616,37 |
|
|
|
|
25 mg comp.ran.x 56 | $33.406,17 | (24/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $8.183,14 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $19.121,41 AF $14.284,76 |
|
|
|
|
3.125 mg comp.ran.x 28 | $6.839,87 | (24/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.983,39 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $4.203,90 AF $2.635,97 |
|
|
|
|
3.125 mg comp.ran.x 30 | $6.838,08 | (24/07/25) |
PAMI |
|
AF $2.051,66 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $4.162,87 AF $2.675,21 |
|
|
|
|
50 mg comp.ran.x 28 | $25.729,10 | (24/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $7.113,63 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $15.352,21 AF $10.376,89 |
|
|
|
|
6.25 mg comp.ran.x 28 | $12.983,80 | (24/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $3.610,02 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $7.334,32 AF $5.649,48 |
|
|
|
|
6.25 mg comp.ran.x 30 | $12.985,10 | (24/07/25) |
PAMI |
|
AF $3.746,66 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $7.226,66 AF $5.758,44 |
|
|
|
|
6.25 mg comp.ran.x 56 | $20.082,33 | (24/07/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $4.734,32 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $11.193,12 AF $8.889,21 |
|
|
|
|
|